0001437749-23-009334.txt : 20230404
0001437749-23-009334.hdr.sgml : 20230404
20230404171821
ACCESSION NUMBER: 0001437749-23-009334
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anderson Raymond
CENTRAL INDEX KEY: 0001362489
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 23799410
MAIL ADDRESS:
STREET 1: C/O MONOPAR THERAPEUTICS INC.
STREET 2: 1000 SKOKIE BLVD., SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-03-31
0001645469
Monopar Therapeutics
MNPR
0001362489
Anderson Raymond
1000 SKOKIE BLVD SUITE 350
WILMETTE
IL
60091
1
0
Common Stock
2023-03-31
4
M
0
2533
A
19263
D
Restricted Stock Units
2023-03-31
4
M
0
2533
0
D
Common Stock
2533
7600
D
Represents shares acquired on vesting and settlement of restricted stock units.
On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
/s/ Kim R. Tsuchimoto, Attorney-in-fact
2023-04-04